Speech-Language Pathologists in South Hempstead, NY Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Talking Mindz, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 417 Woodland Dr, South Hempstead, NY 11550 Phone: 516-884-2816

Ms. Maria Teresa Fritz-rodriguez, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 417 Woodland Dr, South Hempstead, NY 11550 Phone: 516-884-2816    Fax: 516-538-2357

Margaret Clare Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 379 Willow St, South Hempstead, NY 11550 Phone: 516-255-8916

Mrs. Paulette Mclaughlin, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 334 Cedar St, South Hempstead, NY 11550 Phone: 516-489-7162

News Archive

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, and VCA Inc., a leading animal healthcare company in the United States and Canada, today jointly announced Antech Diagnostics, Inc., VCA's laboratory division, has agreed to acquire the assets of AVRL (Abaxis Veterinary Reference Laboratory) from Abaxis for $21 million in cash.

New general manager's banking background beneficial at Global Fund

In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."

Bay Area health care start-up investments down 35% in third quarter

In California's Bay Area, third-quarter venture capital investment in health care-related companies totaled $421.5 million, down 35 percent from $650.6 million in the same period a year earlier, according to research firm VentureSource.

Molecular Health enters into license agreement to supply SafetyMAP software to FDA

Molecular Health has entered into a commercial license to provide the FDA with use of its SafetyMAP software - formally known as Molecular Analysis of Side Effect information (MASE), to provide a comprehensive and dynamic analytical solution for the detection and molecular analysis of drug-induced adverse events for all marketed drugs and for predicting safety issues of new drug candidates.

Read more Medical News

› Verified 1 days ago